12/11/2024 | Press release | Distributed by Public on 12/11/2024 05:59
Guidance as of
December 11, 2024
|
Guidance as of August 21, 2024 (adjusted for delivery expense)
|
Guidance as of
August 21, 2024
|
|
Net sales |
$22.3 billion to $22.5 billion
|
$22.1 billion to $22.4 billion
|
$22.1 billion to $22.4 billion
|
Comparable owned-plus- licensed-plus-marketplace sales change (52 week basis)
|
Down ~1.0% to ~flat versus 2023 | Down ~2.0% to down ~0.5% versus 2023 | Down ~2.0% to down ~0.5% versus 2023 |
Gross margin rate
|
38.2% to 38.3%
|
38.6% to 38.8%
|
39.0% to 39.2%
|
Adjusted EBITDA1 as a percent of total revenue
|
8.0% to 8.4%
|
8.2% to 8.7%
|
8.6% to 9.0%
|
Adjusted diluted earnings per share
|
$2.25 to $2.50
|
$2.34 to $2.69
|
$2.55 to $2.90
|
13 Weeks Ended
November 2, 20241
|
13 Weeks Ended
October 28, 2023
|
|||||||
$ |
% to Net sales |
% to Total revenue |
$ |
% to Net sales |
% to Total revenue |
|||
Net sales | $ | 4,742 | $ | 4,860 | ||||
Other revenue (Note 2) | 161 | 3.4 | % | 178 | 3.7 | % | ||
Total revenue | 4,903 | 5,038 | ||||||
Cost of sales | (2,864) | (60.4 | %) | (2,905) | (59.8 | %) | ||
Selling, general and administrative expenses | (2,064) | (42.1 | %) | (2,040) | (40.5 | %) | ||
Gains on sale of real estate | 66 | 1.3 | % | 5 | 0.1 | % | ||
Impairment, restructuring and other benefits (costs) | 23 | 0.5 | % | (15) | (0.3 | %) | ||
Operating income | 64 | 1.3 | % | 83 | 1.6 | % | ||
Benefit plan income, net | 4 | 2 | ||||||
Settlement charges | - | (7) | ||||||
Interest expense, net | (32) | (35) | ||||||
Loss on early retirement of debt | (1) | - | ||||||
Income before income taxes | 35 | 43 | ||||||
Federal, state and local income tax expense (Note 3) | (7) | (2) | ||||||
Net income | $ | 28 | $ | 41 | ||||
Basic earnings per share | $ | 0.10 | $ | 0.15 | ||||
Diluted earnings per share | $ | 0.10 | $ | 0.15 | ||||
Average common shares: | ||||||||
Basic | 278.4 | 274.7 | ||||||
Diluted | 281.5 | 277.6 | ||||||
End of period common shares outstanding | 277.5 | 273.7 | ||||||
Supplemental Financial Measures: | ||||||||
Gross Margin (Notes 4 and 5) | $ | 1,878 | 39.6 | % | $ | 1,955 | 40.2 | % |
Depreciation and amortization expense | $ | 228 | $ | 231 |
39 Weeks Ended
November 2, 2024 |
39 Weeks Ended
October 28, 2023 |
|||||||
$ |
% to Net sales |
% to Total revenue |
$ |
% to Net sales |
% to Total revenue |
|||
Net sales | $ | 14,525 | $ | 14,972 | ||||
Other revenue (Note 2) | 474 | 3.3 | % | 519 | 3.5 | % | ||
Total revenue | 14,999 | 15,491 | ||||||
Cost of sales | (8,749) | (60.2 | %) | (9,070) | (60.6 | %) | ||
Selling, general and administrative expenses | (5,948) | (39.7 | %) | (5,970) | (38.5 | %) | ||
Gains on sale of real estate | 103 | 0.7 | % | 20 | 0.1 | % | ||
Impairment, restructuring and other benefits (costs) | 5 | - | % | (21) | (0.1 | %) | ||
Operating income | 410 | 2.7 | % | 450 | 2.9 | % | ||
Benefit plan income, net | 12 | 10 | ||||||
Settlement charges | - | (129) | ||||||
Interest expense, net | (94) | (108) | ||||||
Loss on early retirement of debt | (1) | - | ||||||
Income before income taxes | 327 | 223 | ||||||
Federal, state and local income tax expense (Note 3) | (87) | (50) | ||||||
Net income | $ | 240 | $ | 173 | ||||
Basic earnings per share | $ | 0.86 | $ | 0.63 | ||||
Diluted earnings per share | $ | 0.85 | $ | 0.62 | ||||
Average common shares: | ||||||||
Basic | 277.4 | 273.9 | ||||||
Diluted | 281.3 | 277.7 | ||||||
End of period common shares outstanding | 277.5 | 273.7 | ||||||
Supplemental Financial Measures: | ||||||||
Gross Margin (Notes 4 and 5) | $ | 5,776 | 39.8 | % | $ | 5,902 | 39.4 | % |
Depreciation and amortization expense | $ | 657 | $ | 665 |
November 2, 2024 |
February 3, 2024
|
October 28, 2023
|
||||
ASSETS: | ||||||
Current Assets: | ||||||
Cash and cash equivalents | $ | 315 | $ | 1,034 | $ | 364 |
Receivables | 224 | 293 | 218 | |||
Merchandise inventories (Note 5) | 6,257 | 4,361 | 6,025 | |||
Prepaid expenses and other current assets | 416 | 401 | 390 | |||
Income taxes | 34 | - | 88 | |||
Total Current Assets | 7,246 | 6,089 | 7,085 | |||
Property and Equipment - net | 5,161 | 5,308 | 5,813 | |||
Right of Use Assets | 2,322 | 2,305 | 2,784 | |||
Goodwill | 828 | 828 | 828 | |||
Other Intangible Assets - net | 426 | 430 | 431 | |||
Other Assets | 1,310 | 1,286 | 1,185 | |||
Total Assets | $ | 17,293 | $ | 16,246 | $ | 18,126 |
LIABILITIES AND SHAREHOLDERS' EQUITY: | ||||||
Current Liabilities: | ||||||
Short-term debt | $ | 92 | $ | - | $ | 160 |
Merchandise accounts payable | 3,344 | 1,913 | 3,466 | |||
Accounts payable and accrued liabilities | 2,337 | 2,571 | 2,448 | |||
Income taxes | - | 48 | - | |||
Total Current Liabilities | 5,773 | 4,532 | 6,074 | |||
Long-Term Debt | 2,773 | 2,998 | 2,997 | |||
Long-Term Lease Liabilities | 2,961 | 2,986 | 3,034 | |||
Deferred Income Taxes | 712 | 745 | 925 | |||
Other Liabilities | 927 | 950 | 997 | |||
Shareholders' Equity | 4,147 | 4,035 | 4,099 | |||
Total Liabilities and Shareholders' Equity | $ | 17,293 | $ | 16,246 | $ | 18,126 |
39 Weeks Ended November 2, 2024 |
39 Weeks Ended October 28, 2023
|
|||
Cash flows from operating activities: | ||||
Net income | $ | 240 | $ | 173 |
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||
Impairment, restructuring and other (benefits) costs | (5) | 21 | ||
Settlement charges | - | 129 | ||
Depreciation and amortization | 657 | 665 | ||
Benefit plans | 1 | 4 | ||
Stock-based compensation expense | 42 | 45 | ||
Gains on sale of real estate | (103) | (20) | ||
Amortization of financing costs and premium on acquired debt | 9 | 8 | ||
Deferred income taxes | (48) | (43) | ||
Changes in assets and liabilities: | ||||
Decrease in receivables | 68 | 82 | ||
Increase in merchandise inventories | (1,840) | (1,757) | ||
(Increase) decrease in prepaid expenses and other current assets | (19) | 30 | ||
Increase in merchandise accounts payable | 1,327 | 1,334 | ||
Decrease in accounts payable and accrued liabilities | (206) | (302) | ||
Decrease in current income taxes | (71) | (124) | ||
Change in other assets and liabilities | (82) | (87) | ||
Net cash (used) provided by operating activities | (30) | 158 | ||
Cash flows from investing activities: | ||||
Purchase of property and equipment | (399) | (485) | ||
Capitalized software | (250) | (264) | ||
Proceeds from disposition of assets, net | 187 | 36 | ||
Other, net | 7 | (3) | ||
Net cash used by investing activities | (455) | (716) | ||
Cash flows from financing activities: | ||||
Debt issued | 176 | 311 | ||
Debt issuance costs | (1) | (1) | ||
Debt repaid | (313) | (153) | ||
Debt repurchase premium and expenses | 1 | - | ||
Dividends paid | (144) | (135) | ||
Increase in outstanding checks | 47 | 76 | ||
Acquisition of treasury stock | - | (38) | ||
Net cash (used) provided by financing activities | (234) | 60 | ||
Net decrease in cash, cash equivalents and restricted cash | (719) | (498) | ||
Cash, cash equivalents and restricted cash beginning of period | 1,037 | 865 | ||
Cash, cash equivalents and restricted cash end of period | $ | 318 | $ | 367 |
13 Weeks Ended
November 2, 2024
|
13 Weeks Ended
October 28, 2023
|
|||||||
$ |
% to Net sales |
$ |
% to Net sales |
|||||
Credit card revenues, net | $ | 120 | 2.5 | % | $ | 142 | 2.9 | % |
Macy's Media Network revenue, net | 41 | 0.9 | % | 36 | 0.7 | % | ||
Other Revenue | $ | 161 | 3.4 | % | $ | 178 | 3.7 | % |
Net Sales | $ | 4,742 | $ | 4,860 | ||||
39 Weeks Ended
November 2, 2024 |
39 Weeks Ended
October 28, 2023 |
|||||||
$ |
% to Net sales |
$ |
% to Net sales |
|||||
Credit card revenues, net | $ | 362 | 2.5 | % | $ | 424 | 2.8 | % |
Macy's Media Network revenue, net | 112 | 0.8 | % | 95 | 0.6 | % | ||
Other Revenue | $ | 474 | 3.3 | % | $ | 519 | 3.5 | % |
Net Sales | $ | 14,525 | $ | 14,972 |
13 Weeks Ended November 2, 2024 vs.
13 Weeks Ended October 28, 2023
|
||||
Macy's, Inc. | Macy's | |||
Decrease in comparable sales on an owned basis (Note 7)
|
(2.4 | %) | (3.0 | %) |
Impact of departments licensed to third parties and marketplace sales (Note 8) | 1.1 | % | 0.8 | % |
Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis
|
(1.3 | %) | (2.2 | %) |
13 Weeks Ended November 2, 2024 vs.
13 Weeks Ended October 28, 2023
|
||||||||
Macy's, Inc. go-forward business
|
Macy's go-forward business
|
Bloomingdale's*
|
Bluemercury
|
|||||
Increase (decrease) in comparable sales on an owned basis (Note 7)
|
(2.0) | % | (2.6) | % | 1.0 | % | 3.3 | % |
Impact of departments licensed to third parties and marketplace sales (Note 8) | 1.1 | % | 0.8 | % | 2.2 | % | - | % |
Increase (decrease) in comparable sales on an owned-plus-licensed-plus-marketplace basis
|
(0.9 | %) | (1.8 | %) | 3.2 | % | 3.3 | % |
13 Weeks Ended November 2, 2024 vs.
13 Weeks Ended October 28, 2023
|
||
Macy's First 50 locations | ||
Increase in comparable sales on an owned basis (Note 7)
|
1.9 | % |
Impact of departments licensed to third parties (Note 8) | - | % |
Increase in comparable sales on an owned-plus-licensed basis
|
1.9 | % |
39 Weeks Ended November 2, 2024 vs.
39 Weeks Ended October 28, 2023
|
||||
Macy's, Inc. | Macy's | |||
Decrease in comparable sales on an owned basis (Note 7) | (2.5 | %) | (3.0 | %) |
Impact of departments licensed to third parties and marketplace sales (Note 8) | 0.9 | % | 0.9 | % |
Decrease in comparable sales on an owned-plus-licensed-plus-marketplace basis | (1.6 | %) | (2.1 | %) |
39 Weeks Ended November 2, 2024 vs.
39 Weeks Ended October 28, 2023
|
||||||||
Macy's, Inc. go-forward business
|
Macy's go-forward business
|
Bloomingdale's*
|
Bluemercury
|
|||||
Increase (decrease) in comparable sales on an owned basis (Note 7)
|
(2.2) | % | (2.8) | % | 0.3 | % | 3.1 | % |
Impact of departments licensed to third parties and marketplace sales (Note 8) | 0.9 | % | 1.1 | % | 0.4 | % | - | % |
Increase (decrease) in comparable sales on an owned-plus-licensed-plus-marketplace basis
|
(1.3 | %) | (1.7 | %) | 0.7 | % | 3.1 | % |
39 Weeks Ended November 2, 2024 vs.
39 Weeks Ended October 28, 2023
|
||
Macy's First 50 locations | ||
Increase in comparable sales on an owned basis (Note 7)
|
2.0 | % |
Impact of departments licensed to third parties (Note 8) | 0.1 | % |
Increase in comparable sales on an owned-plus-licensed basis
|
2.1 | % |
13 Weeks Ended
November 2, 2024
|
13 Weeks Ended
October 28, 2023
|
|||
Net income | $ | 28 | $ | 41 |
Interest expense, net | 32 | 35 | ||
Loss on early retirement of debt | 1 | - | ||
Federal, state and local income tax expense | 7 | 2 | ||
Depreciation and amortization | 228 | 231 | ||
EBITDA | 296 | 309 | ||
Impairment, restructuring and other (benefits) costs | (23) | 15 | ||
Settlement charges | - | 7 | ||
Adjusted EBITDA | $ | 273 | $ | 331 |
39 Weeks Ended
November 2, 2024
|
39 Weeks Ended
October 28, 2023
|
|||
Net income | $ | 240 | $ | 173 |
Interest expense, net | 94 | 108 | ||
Loss on early retirement of debt | 1 | - | ||
Federal, state and local income tax expense | 87 | 50 | ||
Depreciation and amortization | 657 | 665 | ||
EBITDA | 1,079 | 996 | ||
Impairment, restructuring and other (benefits) costs | (5) | 21 | ||
Settlement charges | - | 129 | ||
Adjusted EBITDA | $ | 1,074 | $ | 1,146 |
13 Weeks Ended
November 2, 2024
|
13 Weeks Ended
October 28, 2023
|
|||||||
Net
Income
|
Diluted
Earnings
Per Share
|
Net
Income
|
Diluted
Earnings
Per Share
|
|||||
As reported | $ | 28 | $ | 0.10 | $ | 41 | $ | 0.15 |
Impairment, restructuring and other (benefits) costs | (23) | (0.08) | 15 | 0.05 | ||||
Settlement charges | - | - | 7 | 0.03 | ||||
Loss on early retirement of debt | 1 | - | - | - | ||||
Income tax impact of certain items identified above
|
5 | 0.02 | (6) | (0.02) | ||||
As adjusted to exclude certain items above
|
$ | 11 | $ | 0.04 | $ | 57 | $ | 0.21 |
39 Weeks Ended
November 2, 2024
|
39 Weeks Ended
October 28, 2023
|
|||||||
Net
Income
|
Diluted
Earnings
Per Share
|
Net
Income
|
Diluted
Earnings
Per Share
|
|||||
As reported | $ | 240 | $ | 0.85 | $ | 173 | $ | 0.62 |
Impairment, restructuring and other (benefits) costs | (5) | (0.01) | 21 | 0.07 | ||||
Settlement charges | - | - | 129 | 0.46 | ||||
Loss on early retirement of debt | 1 | - | - | - | ||||
Income tax impact of certain items identified above
|
1 | - | (38) | (0.13) | ||||
As adjusted to exclude certain items above
|
$ | 237 | $ | 0.84 | $ | 285 | $ | 1.02 |